Clinical Trial Update: Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low-dose ketamine to morphine for vaso-occlusive crisis in sickle cell disease has completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Sickle Cell Disease

Drugs mentioned

• Ketamine (ketamine)
• Morphine (morphine)

Snippet

Sponsor: Makerere University | Conditions: Sickle Cell Crisis, Acute Pain | Phase 4 | Status: COMPLETED | Results posted: 2016-08-03